Search results
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Singapore Finance· 5 hours agoEli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Singapore Finance· 5 hours agoEli Lilly's Business In-Depth With that in mind, let's take a look at Eli Lilly's main business...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Singapore Finance· 13 hours agoThe NYSE ARCA Pharmaceutical Index...sessions. In the last five trading sessions, Pfizer rose the...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
Reuters via Yahoo Singapore Finance· 11 hours ago(Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on...
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials
The Independent via Yahoo News Singapore· 7 minutes agoTirzepatide, which is sold under the brand names Mounjaro and Zepbound – which treat diabetes and...
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
Zacks via Yahoo Singapore Finance· 5 hours agoEli Lilly (LLY) Indianapolis, IN based Eli Lilly and Company, one of the world ...
Morphic Holding, Boeing rise; Paramount, Devon Energy fall, Monday, 7/8/2024
Associated Press via Yahoo Singapore Finance· 6 hours agoMorphic Holding Inc., up $23.90 to $55.74. Eli Lilly is buying the biopharmaceutical company for $3.2 billion. Boeing Co., up $1.01 to ...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Singapore Finance· 8 hours agoThe top 10 holdings account for about 18.68% of total assets under...and standard deviation of...
Mounjaro leads to significantly more weight loss than Ozempic, study suggests
CNN via Yahoo News Singapore· 1 hour agoPeople taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study.